Skip to main content
Log in

Sarcomeric Proteins in Hypertrophied and Failing Myocardium: An Overview

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

This collection of papers covers developments in a rapidly growing area, sarcomeric proteins in hypertrophied and failing myocardium. Advances in our understanding of the biochemistry and biophysics of crossbridge cycling, contributions of thick versus thin filament and the emerging role of titin, the importance and mechanisms of mutations in causing disease, and an integrated understanding of the consequences of sarcomeric protein alterations at the organ level are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alpert NR, Gordon MS. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 1962;202:940–946.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin M. LeWinter MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

LeWinter, M.M., VanBuren, P. Sarcomeric Proteins in Hypertrophied and Failing Myocardium: An Overview. Heart Fail Rev 10, 173–174 (2005). https://doi.org/10.1007/s10741-005-5247-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-005-5247-3

Key Words

Navigation